Nasdaq: CFRX
Navigate ContraFect Corporation
Home
About Us
Overview
Management Team
Board of Directors
Technology
Overview
Lysins
Amurins
Publications / Posters
Video Library
Pipeline
Overview
Exebacase
CF-370
Gram-negative Lysins
Amurins
Investors & Media
Overview
News / Events
Presentations
Company Information
Financial Information
Analyst Coverage
Stock Data
SEC Filings
Corporate Governance
Careers
Contact Us
Press Releases
Investors & Media
Home
Investors & Media
News / Events
Press Releases
All News
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
ContraFect Chairman and CEO Steven C. Gilman Takes Temporary Medical Leave
March 13, 2017
Lisa Ricciardi to Join Board of Directors
February 15, 2017
ContraFect Provides Program Update
January 6, 2017
ContraFect to Present at Biotech Showcase 2017 Conference
January 4, 2017
« Previous
1
2
3
